Myovant stock opened 35% up on Monday: here’s the catalyst Myovant Sciences Ltd (NYSE: MYOV) opened nearly 35% up on Monday after the biopharmaceutical company said it rejected a buyout proposal from its largest shareholder. Myovant is open to considering a better offer Sumitovant Biopharma Ltd had sought to takeover the London-headquartered firm for $2.18 billion, as per the press release. It was willing to [...] The post Myovant stock opened 35% up on Monday: here’s the catalyst appeared first on Invezz.
Author: Wajeeh Khan
Add your comment about this publication